N	Concordance
1	trate an association between cord blood hyperviscosity and later neurologic deve
2	 0.05). Thus, plasma composition causes hyperviscosity and reduced RCD in NAR. F
3	rinogen or triglycerides in determining hyperviscosity of blood and reduced RCD 
4	lvement, and some  patients may develop hyperviscosity syndrome. Other lymphoma
5	ctive mechanism against exacerbation of hyperviscosity by a rising red cell mass
6	  similar to CLL, with the exception of hyperviscosity syndrome associated with 
7	  e used. Patients who have symptoms of hyperviscosity usually undergo plasmaphe
8	 drug appears safe, and hypertension or hyperviscosity syndromes have not been a
9	 as a compensation to avoid much of the hyperviscosity. This explains why we do